Wall Street Zen Upgrades eMagin (NYSE:EMA) to Hold

eMagin (NYSE:EMA – Get Free Report) was upgraded by Wall Street Zen from a “strong sell” rating to a “hold” rating in a research report issued on Saturday, Wall Street Zen reports.

EMA has been the subject of a number of other research reports. Weiss Ratings raised shares of eMagin from a “buy (b-)” rating to a “buy (b)” rating in a research note on Friday, October 23rd. Barclays lowered their price objective on shares of eMagin from $53.00 to $50.00 and set an “equal weight” rating on the stock in a research report on Monday, October 19th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, eMagin currently has an average rating of “Hold” and an average price target of $50.00.

View Our Latest Stock Analysis on eMagin

eMagin Stock Down 0.0%

Shares of EMA opened at $51.13 on Friday. The firm’s 50 day simple moving average is $48.66 and its 200 day simple moving average is $51.20. eMagin has a 1-year low of $45.27 and a 1-year high of $55.49.

Hedge Funds Weigh In On eMagin

Several institutional investors have recently modified their holdings of EMA. Parallel Advisors LLC increased its position in shares of eMagin by 130.9% during the 1st quarter. Parallel Advisors LLC now owns 508 shares of the company’s stock valued at $26,000 after purchasing an additional 288 shares during the last quarter. Gold Investment Management Ltd. purchased a new position in shares of eMagin during the 3rd quarter valued at about $27,000. Mather Group LLC. bought a new stake in eMagin in the 3rd quarter worth approximately $38,000. EverSource Wealth Advisors LLC lifted its position in eMagin by 54.4% in the 1st quarter. EverSource Wealth Advisors LLC now owns 1,093 shares of the company’s stock worth $57,000 after buying an additional 385 shares during the last quarter. Finally, Tompkins Financial Corp bought a new stake in eMagin in the 3rd quarter worth approximately $120,000.

About eMagin

(Get Free Report)

eMagin Corporation developed and manufactured high-resolution OLED microdisplays, compact screens designed for use in near-eye viewing systems. Its products served applications in defense, aerospace, medical, industrial and consumer markets, including head-mounted displays and other wearable devices. The company was known for OLED-on-silicon technology and its direct-patterning process for producing full-color microdisplays. eMagin was based in Hopewell Junction, New York, and Samsung Display completed its acquisition in 2023.

Further Reading

Receive News & Ratings for eMagin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eMagin and related companies with MarketBeat.com's FREE daily email newsletter.